NCT04171037View on ClinicalTrials.gov

Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures

NACompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

October 4, 2019

Primary Completion Date

June 21, 2024

Study Completion Date

June 21, 2024

Conditions

Obstructive Sleep Apnea

Interventions

PROCEDURE

Oxygen Therapy

Receive oxygen via Optiflow THRIVE

PROCEDURE

Oxygen Therapy

Receive oxygen via non-rebreather

OTHER

Questionnaire Administration

Ancillary studies

DEVICE

Optiflow THRIVE

Oxygen Administration

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04171037 - Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures | Biotech Hunter | Biotech Hunter